Inventor · disambiguated record
Joao Siffert
Also filed as: SIFFERT JOAO
0 granted patents·9 pending applications·0 citations·filing 2011–2023
Top patents by PatentIndex Score
9 records- 0175US2024082237A1Pharmaceutical compositions comprising a dextromethorphan compound and quinidine for the treatment of agitation in dementiaAVANIR PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0274US2020352933A1Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of agitation in dementiaAVANIR PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 0372US2022105084A1Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of agitation in dementiaAVANIR PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0469US2019262332A1Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of agitation in dementiaAVANIR PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 0568US2020289499A1Pharmaceutical compositions comprising a dextromethorphan compound and quinidine for the treatment of agitation in dementiaAVANIR PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 0664US2017333423A1Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of agitation in dementiaAVANIR PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 0760US2016143901A1Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of agitation in dementiaAVANIR PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 0855US2019111047A1Pharmaceutical compositions comprising a dextromethorphan compound and quinidine for the treatment of agitation in dementiaAVANIR PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 0938US2012082650A1Methods for treating parkinson's disease and other disorders of dopaminergic neurons of the brainBARTUS RAYMOND T·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joao Siffert files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →